Molecular locker probe enrichment of gene fusion variants from matched patient liquid biopsy specimens for magneto-bioelectrocatalytic nanosensing. Issue 11 (2nd March 2022)

• Record Type: Journal Article
• Authors: Koo, Kevin M.; Trau, Matt
• Is Part Of: Nanoscale. Volume 14:Issue 11(2022)
• Page Start: 4225
• Page End: 4233
• Publication Date: 2022-03-02
• Subjects: Nanoscience -- Periodicals; Nanotechnology -- Periodicals; 620.505
• DOI: 10.1039/d1nr07845c
• Languages: English
• ISSNs: 2040-3364

Abstract

Abstract : This work introduces a novel nanosensing technique using modified nucleic acid-based biotarget enrichment and magneto-bioelectrocatalytic cycling readout for analysis of three fusion mutant variants in matched plasma and urine specimens ( n = 80). Abstract : The accurate and sensitive analysis of recurrent gene fusion mutant variants in circulating tumor nucleic acids (NAs) of patient liquid biopsy samples is crucial for realizing clinical potential for cancer screening, diagnostics, and therapeutics. Gene fusion analysis is especially challenging in patient liquid biopsy samples because of trace biotarget levels in high non-target background of highly similar native and variant NA sequences. Herein, we describe accurate analysis of three prostate cancer gene fusion mutant variants in matched plasma and urine specimens from real cancer patients and healthy controls ( n = 80) by (i) direct locker probe enrichment of multiple gene fusion mutant variants without tedious upstream sample processing; (ii) magneto-bioelectrocatalytic cycling readout using both NA-intercalating and freely diffusive redox probes for superior signal enhancement. For each mutant variant, an ultrabroad dynamic range (10–10 5 copies) was achieved with enhanced 10 copies (zmol) detection limit. With the combination of locker probe enrichment and magneto-bioelectrocatalytic cycling readout for NA mutant variant analysis, the potential of non-invasive liquid biopsies may be exploited for the benefit of cancer patients.